Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Yanju Lv"'
Autor:
Dan Tian, Chong Teng, Yanju Lv, Xiaozhuo Duan, Yi Wang, Xiaowei Song, Qiuying Jiang, Dayong Huang, Tao Xin, Yu Yang, Li Li
Publikováno v:
Discover Oncology, Vol 15, Iss 1, Pp 1-5 (2024)
Abstract Cutaneous squamous cell carcinoma (CSCC) is common among the elderly, typically treated with surgery. However, for surgery-ineligible patients or those with non-healing wounds progressing to malignant ulcers, non-surgical local treatments ar
Externí odkaz:
https://doaj.org/article/545e034a2a694ffaa45e83fa62701f2c
Autor:
Yinghua Jin, Qiuyu Zhao, Chengjuan Fan, Xiaowei Song, Chong Teng, Yanju Lv, Qiuying Jiang, Dayong Huang, Li Li, Weixi Shen, Tao Xin
Publikováno v:
Asian Journal of Surgery, Vol 47, Iss 3, Pp 1378-1382 (2024)
Backgrounds: Radiofrequency ablation (RFA) is known to destroy tumoral tissue and activate immune cells. This study aimed to investigate the impact of RFA on peripheral T-cell responses and its relationship with tumor origin and hepatitis status. Met
Externí odkaz:
https://doaj.org/article/365e87a7b2cd4febaf7c390845a1ba1c
Publikováno v:
Frontiers in Genetics, Vol 13 (2022)
Background: Studies have reported that coppers are involved in the tumorigenesis and development of tumor. In herein, we aimed to construct a prognostic classification system for lung adenocarcinoma (LUAD) associated with cuproptosis.Methods: Samples
Externí odkaz:
https://doaj.org/article/4f5424ef29dd4df8b9ecef08390ce06e
Autor:
Tianyi Liu, Zhipeng Wang, Xue-Li Yuan, Ning Yang, Yuying Zhao, Hui Wang, Yanju Lv, Jingyu Chen
Publikováno v:
OncoTargets and Therapy. 13:5135-5143
Purpose Glioma (GM) usually presents with an aggressive behavior and has a poor survival outcome. The abnormal expression of circular RNAs (circRNAs) has already been detected in GM, and circ_0079586 was found to have an increased expression in GM tu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5ccfe525e48a86705c985ee6e99917b4
https://doi.org/10.2147/ott.s234758
https://doi.org/10.2147/ott.s234758
Ceritinib shows efficacy in ALK+ NSCLC patients with BM. However, the disease will inevitably progress over time due to acquired resistance. We now report a case with BM from advanced lung adenocarcinoma with ALK mutations who exhibited a surprising
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::42f74a574c16c76c7e06b8c7885e53ec
https://doi.org/10.22541/au.161671669.94056751/v1
https://doi.org/10.22541/au.161671669.94056751/v1
Publikováno v:
Journal of Cellular and Molecular Medicine
Liver hepatocellular carcinoma (LIHC) can be detected by the immune system; however, it acquires features for evasion of immune surveillance during its origin and development. Long non‐coding RNAs (lncRNAs) are critical as immune regulators in canc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9bb392872467889dc6f3e951da724e33
https://pubmed.ncbi.nlm.nih.gov/32910548
https://pubmed.ncbi.nlm.nih.gov/32910548
Autor:
Jingyu, Chen, Tianyi, Liu, Hui, Wang, Zhipeng, Wang, Yanju, Lv, Yuying, Zhao, Ning, Yang, Xueli, Yuan
Publikováno v:
OncoTargets and therapy
Purpose Glioma (GM) usually presents with an aggressive behavior and has a poor survival outcome. The abnormal expression of circular RNAs (circRNAs) has already been detected in GM, and circ_0079586 was found to have an increased expression in GM tu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2d70157e04be9f1bb344025a948f248e
https://pubmed.ncbi.nlm.nih.gov/32606734
https://pubmed.ncbi.nlm.nih.gov/32606734
Autor:
Qiuying Jiang, Li Li, Tao Xin, Ying Liu, Chengjuan Fan, Chong Teng, Lingxiao Wei, Yanju Lv, Xiaowei Song, Dayong Huang, Yinghua Jin, Weixi Shen
Publikováno v:
Scientific Reports
Scientific Reports, Vol 8, Iss 1, Pp 1-9 (2018)
Scientific Reports, Vol 8, Iss 1, Pp 1-9 (2018)
The poor prognosis in non-small-cell lung cancer has driven the development of novel targeted therapies. Vascular endothelial growth factor is the most potent force in mediating tumor angiogenesis, and many angiogenesis inhibitors have been developed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ed249d130899ac12c2553606ed9d067
http://europepmc.org/articles/PMC6203857
http://europepmc.org/articles/PMC6203857
Autor:
Dayong Huang, Chengjuan Fan, Yinghua Jin, Lingxiao Wei, Tao Xin, Li Li, Qiuying Jiang, Yanju Lv, Xiaowei Song, Chong Teng, Ying Liu
Publikováno v:
Journal of Clinical Oncology. 36:e24005-e24005
e24005Background: The poor prognosis in non-small cell lung cancer has driven the development of angiogenesis inhibitors. However, information on clinical characteristics of inhibitors with differe...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bb37997c76bf29932a0aa0373ffa359d
https://doi.org/10.1200/jco.2018.36.15_suppl.e24005
https://doi.org/10.1200/jco.2018.36.15_suppl.e24005